Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. [electronic resource]
Producer: 19920727Description: 214-29 p. digitalISSN:- 0149-2918
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Amoxicillin -- adverse effects
- Amoxicillin-Potassium Clavulanate Combination
- Bacterial Infections -- drug therapy
- Bronchitis -- drug therapy
- Cephalosporins -- adverse effects
- Chronic Disease
- Clavulanic Acids -- adverse effects
- Drug Therapy, Combination -- adverse effects
- Female
- Haemophilus Infections -- drug therapy
- Haemophilus influenzae
- Humans
- Male
- Middle Aged
- Moraxella catarrhalis
- Neisseriaceae Infections -- drug therapy
- Pneumococcal Infections -- drug therapy
- Single-Blind Method
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.